# CLEAR Sepsis Clinical Study

> **NCT03231956** · — · UNKNOWN · sponsor: **Edwards Lifesciences** · enrollment: 182 (estimated)

## Conditions studied

- Sepsis

## Interventions

- **DEVICE:** ClearSight™ / EV1000NI Clinical Platform

## Key facts

- **NCT ID:** NCT03231956
- **Lead sponsor:** Edwards Lifesciences
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2017-06-29
- **Primary completion:** 2021-12-31
- **Final completion:** 2022-06-30
- **Target enrollment:** 182 (ESTIMATED)
- **Last updated:** 2020-03-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03231956

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03231956, "CLEAR Sepsis Clinical Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT03231956. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*